NEULANDLAB.BO
Neuland Laboratories Limited
1W: -0.1%
1M: -3.1%
3M: -30.3%
YTD: -9.1%
1Y: -16.0%
3Y: +714.1%
5Y: +900.3%
₹12,072.00 ($128.51)
+41.05 (+0.34%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₹154.9B ($1.6B)
52W Range10060-19748.4
Volume1,867
Avg Volume2,703
Beta-0.01
Dividend₹12.00
Analyst Ratings
No analyst coverage
Company Info
CEODavuluri Sucheth Rao
Employees1,643
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2000-12-18
Websiteneulandlabs.com
Phoenix IVY Building
Hyderabad 500033
IN
Hyderabad 500033
IN
91 40 6761 1600
About Neuland Laboratories Limited
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, central nervous system, fluoroquinolones, antipsychotic, antibacterial, and anti-parkinson. It also provides custom manufacturing solutions, as well as peptide synthesis services. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
Latest News
No recent news
Recent Insider Trades
No insider trades found